SFIO Smokefree Innotec Inc

[Jav992]

Smokefree Innotec Begins Drawing on $417,000 Line of Credit to Fund Distributors

.Companies:Smokefree Innotec, Inc..Press Release Source: Smokefree Innotec, Inc. On Friday April 16, 2010, 6:00 am EDT
NASHVILLE, TN--(Marketwire - 04/16/10) - Smokefree Innotec, Inc. (Pinksheets:SFIO - News) (http://www.sfio.us or http://www.realsmokefree.com) announced today that it has received confirmation from Manfred Bogaert, General Manager Europe of its Belgium operations, that Smokefree Innotec has received correspondence evidencing that effective April 13, 2010, KBC Bank of Antwerp granted a 300,000 EU ($417,000) credit line to the company's European subsidiary Smokefree Innotec bvba, with offices at Antwerp, Belgium.

The credit line established was used immediately to transmit funds in the amount of 242,000 EU ($336,380 at the current exchange rate of 1.39). The purpose of the wire transmitting the funds is to secure the shelf space for the vending machines SFIO has under contract with Conway, a leading distributor in Europe, to stock 6000 vending machines. Of the amount advanced to Conway, 42,000 EU ($58,380) represents a tax deposit that is expected to be returned within 14 days as sales progress.

[Jav992]

NASCO Teams with Smokefree Innotec in Joint Venture for International Distribution



.Companies:Smokefree Innotec, Inc..Press Release Source: Smokefree Innotec Inc. On Monday June 14, 2010, 9:00 am
NASHVILLE, Tenn.--(BUSINESS WIRE)--Ralph Angiuoli, Chairman of NASCO Specialty Brands, LLC. and former President of R.J. Reynolds Tobacco, and Thomas Schroepfer, CEO of Smokefree Innotec Inc. (PINKSHEETS: SFIO - News) (http://cts.businesswire.com/ct/CT?id...e3a1189ddbfbd1 or http://cts.businesswire.com/ct/CT?id...bcb088ecd53bcb) announced today that they have signed a joint venture to develop new national and international branding and distribution of their respective company products. Mr. Angiuoli stated, “We look forward with enthusiasm to SFI’s applying its proprietary methods to NASCO’s tobacco-free cigarette products, already in worldwide distribution, to create additional new products dispensing nicotine employing SFI’s nanotechnology and NASCO’s packaging and manufacturing capabilities.”

Mr. Schroepfer added “We are very pleased to cement our relationship with NASCO, an experienced company, to what we feel to be profitable for both corporations and their shareholders. We look forward to expanding this relationship into additional products and distribution channels worldwide. SFI’s penetration into the international market is already rapidly expanding as reflected by a $70,000 initial order received from one of the largest vending machine operators in the European Union, with over 70,000 locations.”

The management of both companies acknowledged their appreciation that they were brought together in this joint venture as another one of the successful business partnerships initiated by Leading Points Corporation, (http://cts.businesswire.com/ct/CT?id...90e12eab12dcb4) whose mission is matching industry leaders in order to capture market share.

[Jav992]

Smokefree Innotec Relocates Corporate Headquarters to Southern California



.Companies:Smokefree Innotec, Inc..Press Release Source: Smokefree Innotec, Inc. On Thursday June 17, 2010, 9:00 am
IRVINE, Calif.--(BUSINESS WIRE)--Smokefree Innotec, Inc. (Pinksheets:SFIO) (http://www.sfio.us or http://www.realsmokefree.com) announced today that it has relocated its corporate headquarters to 15615 Alton Parkway, Suite 450, Irvine, California 92618. The new corporate office phone number is toll free 888-850-4022 and the fax number is 949-333-0857. The company’s Investor Relations line is now 949-813-5729.

[Jav992]

Press Release Source: Smokefree Innotec, Inc. On Monday June 28, 2010, 9:00 am
NASHVILLE, Tenn.--(BUSINESS WIRE)--Smokefree Innotec, Inc. (Pinksheets:SFIO) Thomas Schroepfer, CEO, (http://www.sfio.us or http://www.realsmokefree.com) announced today that the Company is shipping its first order of 1500 cartons (each carton contains 10 packs) of Smokefree products to Conway Distribution in Belgium.

Mr. Schroepfer further stated, ”This delivery marks the beginning of selling SFI’s Smokefree products beginning with the 6000 vending machines that Conway controls in Belgium. Conway is the biggest distributor in smokers’ product in Belgium, the Netherlands and Germany. Selling in Belgian vending machines is the first step to develop SFI’s Smokefree solutions in vending machines and retail outlets in Northwest Europe.”

SFI’s European General Manager Manfred Bogaert commented, “I believe that the extensive distribution knowledge and financial strength of Conway makes it the ideal partner in this part of the world.”

According to SFI's C.E.O. Thomas Schroepfer, more announcements about European distribution will be made during his forthcoming European trip to visit multi-level marketing operations and distributors in the Benelux and Germany to finalize negotiations. Says Schroepfer: “The Company, expected to generate significant sales in Q2, encountered transportation delays from the recent Iceland volcano dust storms impacting schedules for our products and customers, but we are finally on track and headed for substantial revenues in the 3rd quarter of 2010.”

[Jav992]

Smokefree Innotec Announces Access to New European Production and Distribution Facilities

Press Release Source: Smokefree Innotec, Inc. On Tuesday July 20, 2010, 9:00 am
IRVINE, Calif.--(BUSINESS WIRE)--Smokefree Innotec, Inc. (Pinksheets: SFIO - News) Thomas Schroepfer, CEO, (http://www.sfio.us or http://www.realsmokefree.com) today stated that his extended European trip, undertaken at his own expense, has resulted in SFI developing new and significant contacts for new product marketing and production, in addition to solidifying existing arrangements for Euromarketing of current SFI product lines. Upon his return this past weekend, he informed the SFI Board of Directors that he had conducted a review with Manfred Boegart, SFI Director of European Operations, of all SFI relationships with its existing distributors, and found that any impediments and missing actions had been successfully dealt with and resulted in establishing stronger and more effective channels for SFI nicotine and non-nicotine flavored product distribution. He stated recent shipments to fill orders evidence that, and details of sales and scheduled shipments against SFI bank lines of credit will be released to the public pending approvals by customers to do so.

Mr. Schroepfer went on to state that he is finalizing negotiations to acquire new smokefree cigarette products already in distribution in Europe, and gain access to such additional new distribution for existing SFI products, details to be released as agreements are executed. He further informed the Board that an additional source for smokefree cigarette production equipment has been contacted to arrange for the import of that equipment for commencement of production within the United States.

Summarizing his trip, Mr. Schroepfer stated, “In my view, a great deal was accomplished in reinforcing confidence, enhancing our market position, and moving existing distribution arrangements forward to the complete satisfaction of our customers, as well as developing new channels and accessing new products and manufacturing capabilities. Shipments are in process to key distributors, but it is premature to disclose details and names at this time to avoid unwarranted attempts by unauthorized outside parties to contact them, which interferes with our relationships with these distributors, some of whom have already expressed to us deep resentment and dissatisfaction with any such attempts.”

[chuck44l]

Press Release Source: Smokefree Innotec, Inc. On Tuesday August 3, 2010, 9:00 am
IRVINE, Calif.--(BUSINESS WIRE)--Smokefree Innotec, Inc. (Pinksheets:SFIO - News) Thomas Schroepfer, CEO, (http://www.sfio.us or http://www.realsmokefree.com) announced today that the Company has executed a Joint venture agreement with a Colorado research and development corporation focusing on natural holistic and herbal medical compounds, operating out of laboratory facilities located in Colorado Springs. The business objective is to jointly develop and market several smoke-free high tech natural and herbal pharmacological products, initially based upon an oral delivery system utilizing the innovative technology developed for the “REAL Smokefree Cigarette™”. Under this joint venture Smokefree Innotec, Inc. will provide its smoke-free products and devices, and its venture partner will provide all the medical extract formulations to the Company.

Mr.Schroepfer stated, “This partnering will put Smokefree Innotec in the forefront of marketing our devices, delivering medical formulations of pharmacological extracts to dispensaries and healing centers already in existence, in compliance with applicable federal and state regulations. Because the information is highly sensitive and proprietary to the Company, We have agreed to withhold the name of our joint venture partner pending the necessary approval to release that information. The entry into this arena represents a significant step forward in extending our distribution of Smokefree’s products in North America. The material fact here is that we have created this joint venture with a highly reputable well established research laboratory opening the way for substantial future business. Further information to the public will be released as it becomes appropriate.”

About Smokefree Innotec, Inc: www.smokefree-innotec.com

Smokefree Innotec, Inc. is in the business of designing, developing, manufacturing and marketing hi-tech, nicotine and non-nicotine cigarette-like delivery devices which are completely smoke and vapor-free and tobacco-free. Smokefree Innotec’s products are designed to protect the non-smoker from second hand smoke and all its effects while providing the smoker a way to enjoy a smoke-free cigarette anywhere, including places where smoking tobacco or similar substances is prohibited. Further, our products will allow the smoker to enjoy smoking either nicotine or flavored non-nicotine cigarettes while not having to worry about the offensive dangers and ill effects of regular cigarette smoking. However Smokefree Innotec products are not intended for any prevention or therapeutic treatment of any disease.

A number of statements referenced in this Press Release are forward-looking statements, which are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995, and within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, and goals, assumption of future events or performance are not statements of historical fact and may be “forward-looking statements.” Forward-looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements in this Release may be identified through the use of words such as “expects,” “will,” “anticipates,” “estimates,” “believes,” or statements indicating certain actions “may”, “could,” or “might” occur. Such statements reflect the current views of Smokefree Innotec Inc. with respect to future events and are subject to certain assumptions, including those described in this release. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products, services, and technologies, competitive market conditions, successful integration of acquisitions, the ability to secure additional sources of financing, the ability to reduce operating expenses, and other factors. The actual results that the Company achieves may differ materially from any forward-looking statements due to such risks and uncertainties. Smokefree Innotec Inc. does not undertake any responsibility to update the “forward-looking” statements contained in this news release. Disclosures made in this Press Release are limited by good business practice and to that permitted to the public by applicable securities regulations, both Federal and State, including rights granted to shareholders under the Nevada Revised Statutes NRS 78.257 regarding limitations of preferential and selective disclosure of confidential Company information.



Contact:
Smokefree Innotec, Inc.Kim Carroll, Investor Relations949-813-5729

[Jav992]

Smokefree Innotec Announces Joint Venture with Colorado Based Laboratories

Press Release Source: Smokefree Innotec, Inc. On Tuesday August 3, 2010, 9:00 am
IRVINE, Calif.--(BUSINESS WIRE)--Smokefree Innotec, Inc. (Pinksheets:SFIO - News) Thomas Schroepfer, CEO, (http://www.sfio.us or http://www.realsmokefree.com) announced today that the Company has executed a Joint venture agreement with a Colorado research and development corporation focusing on natural holistic and herbal medical compounds, operating out of laboratory facilities located in Colorado Springs. The business objective is to jointly develop and market several smoke-free high tech natural and herbal pharmacological products, initially based upon an oral delivery system utilizing the innovative technology developed for the “REAL Smokefree Cigarette™”. Under this joint venture Smokefree Innotec, Inc. will provide its smoke-free products and devices, and its venture partner will provide all the medical extract formulations to the Company.

Mr.Schroepfer stated, “This partnering will put Smokefree Innotec in the forefront of marketing our devices, delivering medical formulations of pharmacological extracts to dispensaries and healing centers already in existence, in compliance with applicable federal and state regulations. Because the information is highly sensitive and proprietary to the Company, We have agreed to withhold the name of our joint venture partner pending the necessary approval to release that information. The entry into this arena represents a significant step forward in extending our distribution of Smokefree’s products in North America. The material fact here is that we have created this joint venture with a highly reputable well established research laboratory opening the way for substantial future business. Further information to the public will be released as it becomes appropriate.”

[Jav992]

Cannabis Science Signs Joint Venture With Smokefree Innotec Inc. to Develop High-Tech Smoke-Free Vaporized Medical Cannabis Products

Press Release Source: Cannabis Science, Inc. On Thursday August 12, 2010, 3:03 pm EDT

COLORADO SPRINGS, Colo., Aug. 12, 2010 (GLOBE NEWSWIRE) -- Cannabis Science (OTCBB:CBIS - News), a pioneering U.S. biotech company developing pharmaceutical cannabis products announced today that it has executed a Joint Venture Agreement with Smokefree Innotec Inc. (Pink Sheets:SFIO - News). The objective of the joint venture is to develop and market several high-tech smoke-free vaporized medical cannabis pharmaceutical products. Under the joint venture, Smokefree Innotec, Inc. will provide its high-tech smoke-free vapor technology devices, and Cannabis Science will provide all the medical cannabis extract formulations. Both parties equally share in the revenues derived from this Joint Venture.

Dr. Robert Melamede, President & CEO of Cannabis Science Inc., stated, "Many patients smoke medical cannabis because it gives them rapid relief that allows them to monitor their usage. Smokefree Innotec's technology allows the patients even greater convenience and dosage control than smoking, without all of the possible health and social/legal problems associated with smoking. Cannabis Science will provide a variety of standardized medical marijuana formulations to be used with the Smokefree Innotec products, so that patients can self-monitor their dosages. Of course, these products will be of even greater value to patients who do not like to smoke since vaporizing minimizes the irritating and harmful effects caused by direct smoke contacting the lungs."

Thomas Schroepfer, CEO of Smokefree, stated, "We have entered into this joint venture with Cannabis Science to utilize their innovative knowledge of the science of cannabis and their laboratory research expertise. These competencies coupled with our high-tech products open the door for substantial product distribution channels on an international level. Our initial target markets will be the expanding number of States that have approved medical marijuana use according the applicable federal and state regulations. With our international distribution of Smokefree Innnotec products already well established, the entry into the Medical Cannabis market represents our commitment to significantly expand and distribute the new products across North America, while we identify and secure a market share of rapidly growing industries such as Medical Cannabis, Military Retail and Government service."

The managements of both companies are grateful for the expert guidance provided by retired Lieutenant Cornel Kevin Sullivan of Leading Points Corporation, (www.leadingpoints.com). Leading Points initiated the relationship between Cannabis Science and Smokefree Innotec that resulted in this joint venture. Leading Points Corporation, whose mission is matching industry leaders in order to capture market share for government and military distribution of products will continue in that capacity to further progress possible government and military use of the products developed from this joint venture.

[Jav992]

Smokefree Innotec Confirms Joint Venture with Cannabis Science, Examines Potential of Medical Cannabis Market

Press Release Source: Smokefree Innotec, Inc. On Wednesday August 18, 2010, 6:39 pm EDT
IRVINE, Calif.--(BUSINESS WIRE)--Smokefree Innotec, Inc. (Pink Sheets:SFIO) Thomas Schroepfer, CEO, (http://www.sfio.us or http://www.realsmokefree.com) confirmed today the announcement by the Biotech company Cannabis Science (OTCBB:CBIS - News) regarding entering into a joint venture agreement to develop and market several high-tech smoke-free vaporized medical cannabis pharmaceutical products, as released by CBIS on August 13. He stated, “Pursuant to the joint venture, Smokefree Innotec Inc will supply its high-tech smoke-free vapor technology devices and Cannabis Science will provide all the medical cannabis extract formulations.”

George Roth, CFO stated, “Our business of designing, developing, manufacturing and marketing hi-tech, nicotine and non-nicotine cigarette-like delivery devices which are completely smoke and vapor-free and tobacco-free, represents an excellent partnering with Cannabis Science to fill their needs for production and distribution in the fourteen US States that currently approve the medical use of cannabis. This partnering further represents our commitment to continue to expand our network of cutting edge technology partners to create ever expanding product lines, for devices delivering both nicotine and herbal therapeutic extracts, as seen on our web site http://www.sfio.us.”

Mr. Roth added, “It is worth repeating that this partnering with Cannabis Science will put Smokefree Innotec in the forefront of marketing devices delivering medical formulations of pharmacological extracts to dispensaries and healing centers already in existence, in compliance with applicable federal and state regulations. With the anticipated voter approval of Prop 19 in California, we believe the number of dispensaries and related retail establishments for marijuana and marijuana accessories will multiply rapidly.

“From the news reports, a majority of Californians continue to voice their support for Prop. 19, which would eliminate penalties for the private possession and use of marijuana by adults, and allow local governments to regulate retail cannabis production and sales. Further, the results of a series of randomized, placebo-controlled clinical trials assessing the efficacy of inhaled marijuana consistently show that cannabis holds therapeutic value comparable to conventional medications, according to the findings of a 24-page report issued Wednesday to the California state legislature by the California Center for Medicinal Cannabis Research (CMCR).”

(See http://www.cmcr.ucsd.edu/CMCR_REPORT_FEB17.pdf.)

In an earlier release, Dr. Robert Melamede, President and CEO of Cannabis Science Inc., stated, "Many patients smoke medical cannabis because it gives them rapid relief that allows them to monitor their usage. Smokefree Innotec's technology allows the patients even greater convenience and dosage control than smoking, without all of the possible health and social/legal problems associated with smoking. Cannabis Science will provide a variety of standardized medical marijuana formulations to be used with the Smokefree Innotec products, so that patients can self-monitor their dosages. Of course, these products will be of even greater value to patients who do not like to smoke since vaporizing minimizes the irritating and harmful effects caused by direct smoke contacting the lungs."

Mr. Roth added, in San Diego, California alone, a grand jury report “estimated there are at least 5,000 medical marijuana patients in San Diego County, and it’s probable there are considerably more. Medical marijuana advocates say there could be 60,000.” “There are more marijuana dispensaries in Los Angeles than there are Starbucks,” candidate Chris Kelly said in a June 23rd San Diego Tribune article. According to Wikipedia, “Across California there are an estimated 2,100 dispensaries, co-operatives, wellness clinics and taxi delivery services in the sector known as 'cannabusiness.' That is more than all the Starbucks, McDonald’s and 7-Eleven outlets in the state put together17, according to The Sunday Times.”

Mr. Schroepfer added, “With our international distribution of Smokefree Innnotec products already well established, the entry into the Medical Cannabis market represents our commitment to significantly expand and distribute new products across North America. Identifying and securing market share of rapidly growing fields such as Medical Cannabis, Military Retail and Government service will continue to be led by the efforts of our partners at Leading Points Corporation. The management of both companies acknowledged their appreciation that they were brought together in this joint venture as another one of the successful business partnerships initiated by Leading Points Corporation (www.leadingpoints.com), whose mission is matching industry leaders in order to capture market share.”

[Jav992]

Smokefree Innotec Retains Perfect Entertainment Group for European PR

Press Release Source: Smokefree Innotec, Inc. On Tuesday August 24, 2010, 9:00 am
IRVINE, Calif.--(BUSINESS WIRE)--Smokefree Innotec, Inc. (Pink Sheets:SFIO) Thomas Schroepfer, CEO, (http://www.sfio.us or http://www.realsmokefree.com) announced today the retention of a well-known European public relations company, Perfect Entertainment Group. The firm will provide public relations services to promote the exposure of the Company and enhance the brand awareness of its products by utilizing internet social networking tools and channels, including the use of blogs, Twitter, Facebook, YouTube, television and other News services for the Company; and such other public relations services as may be mutually agreed upon.

George Roth, CFO, added, “Included in the services to be provided by Perfect Entertainment Group are contacting financial and industry specific media, providing Company shareholder and investor communication email services, assisting on public disclosure requirements on Company website, assisting the company on Press Releases, and introducing local Press Agents and arranging for Press conferences. Perfect Entertainment Group will also publish a Corporate News Letter to 1.5 Million fund managers, venture capital companies, banks brokers, decision makers, and professional investors throughout Europe.”

He added, “The terms of the compensation provided by SFI are not being disclosed, but are strictly monetary and do not involve the issuance of SFI shares. Their performance under the contract is for an initial period of the next 120 days, and may be extended at the option of SFI for like consideration, particularly if their activities are successful in contacting the necessary advocate, solicitors, accounts and sponsoring brokers to open the way for the possibility of SFI being listed on the Frankfurt Exchange.”